Back to 
Woodline Partners LP
Woodline Partners LP
PRAX
Showing 7 of 9 quarters
Position history for Woodline Partners LP's holdings in PRAXIS PRECISION MEDICINES I
Yes. Woodline Partners holds 200,013 shares of PRAX (Praxis Precision Medicines), worth $67M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Woodline Partners has held PRAX since Q4 2024, across 7 quarterly 13F filings. PRAX is 0.2% of Woodline Partners' reported 13F portfolio.
Current Value
$67M
Current Shares
200,013
Total Value Change
+$66.2M
Total Shares Change
+190,065
Quarter-by-Quarter History